IndraLab

Statements


Mutated SCN5A activates LQT3 [. 1 / 1
| 1

reach
"To re-investigate this latter point and potentially assess pharmacological response profiles, we have established a patient derived hiPSC model harbouring a heterozygous SCN5A mutation (p.R1644H) mutation that is known to cause LQT3 [XREF_BIBR]."